Western blot analysis of important signaling molecules involved in prostate cancer demonstrated that the AR protein expression was significantly reduced by arctigenin treatment compared to HF control, along with a significantly increased protein expression of Nkx3.1 (Fig. 4A,B). The gene discussed is NKX3-1; the disease is Familial prostate cancer.